harvoni
gilead sciences israel ltd - ledipasvir; sofosbuvir - film coated tablets - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adults.
harvoni tablet
gilead sciences canada inc - sofosbuvir; ledipasvir - tablet - 400mg; 90mg - sofosbuvir 400mg; ledipasvir 90mg - hcv polymerase inhibitors
harvoni 90mg400mg tablets
gilead sciences international ltd - ledipasvir; sofosbuvir - tablet - 90mg ; 400mg
harvoni
gilead sciences israel ltd - ledipasvir; sofosbuvir - film coated tablets - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adults.
harvoni
gilead sciences israel ltd - ledipasvir; sofosbuvir - film coated tablets - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adults.
harvoni 400/90 mg film-coated tablet film-coated tablet
gilead sciences limited, ireland - sofosbuvir,ledipasvir - film-coated tablet - 400,90 mg,